/PLSI

PLSI Stock - Phoenix Life Sciences International Limited

Q: What is the analyst price target for PLSI?

Analyst price target information is not currently available for PLSI.

Q: What is PLSI's market cap?

Market capitalization information is not currently available for PLSI.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00-99.99%

$0.82 (-99.99%) • Aug 28

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for PLSI

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2015

FY2016

FY2017

FY2018

FY2019

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta204.07

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2019	FY2018	FY2017	FY2016	FY2015
Revenue	N/A	N/A	N/A	$18,410	$23,549
Gross Profit	N/A	N/A	N/A	$12,477	$9,584
Gross Margin	N/A	N/A	N/A	67.8%	40.7%
Operating Income	$-3,062,000	$-458	$-35,811	$-497,217	$722
Net Income	$-3,117,000	$-76,590	$-254,710	$-787,819	$-11,974,946
Net Margin	N/A	N/A	N/A	-4279.3%	-50851.2%
EPS	$-89.11	$-2.46	$-8.63	$-28.81	$-1060.10

Company Overview

Phoenix Life Sciences International Limited operates as a healthcare solutions company in the United States and internationally. The company focuses on advancing research, integrating programs, and manufacturing of products that target and treat diabetes, pain, and cancers, as well as address psychological, gastrointestinal, autoimmune, neurological, and sleep disorders. It offers oral soft gel capsules, thin film dissolvable strips, transdermal patches, sublingual oral sprays, suppositories, and topical creams. The company was formerly known as Stem Bioscience, Inc. and changed its name to Phoenix Life Sciences International Limited in May 2018. Phoenix Life Sciences International Limited was incorporated in 2009 and is headquartered in Las Vegas Nevada.

Visit Website

Frequently Asked Questions about PLSI

What is PLSI's current stock price?

Phoenix Life Sciences International Limited (PLSI) is currently trading at $0.00 per share. The stock has moved -99.99% today.

What is the analyst price target for PLSI?

No analyst price targets are currently available for this stock.

What sector is Phoenix Life Sciences International Limited in?

Phoenix Life Sciences International Limited operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is PLSI's market cap?

Phoenix Life Sciences International Limited has a market capitalization of $0.00 billion, making it a small-cap company.

Does PLSI pay dividends?

No, Phoenix Life Sciences International Limited does not currently pay a dividend to shareholders.